NasdaqGS:TXGLife Sciences
Assessing 10x Genomics (TXG) Valuation After Recent Share Price Momentum
With no single headline event driving it today, 10x Genomics (TXG) is experiencing a combination of mixed recent share returns and ongoing interest in its genomics tools business, prompting closer attention from investors.
See our latest analysis for 10x Genomics.
The recent 3.5% 1 day share price gain to US$18.12 sits against a 30 day share price return of 12% and a 1 year total shareholder return of 47%. However, the 3 and 5 year total shareholder returns remain sharply negative, suggesting...